221 related articles for article (PubMed ID: 20159990)
1. Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma.
Kobayashi E; Masuda M; Nakayama R; Ichikawa H; Satow R; Shitashige M; Honda K; Yamaguchi U; Shoji A; Tochigi N; Morioka H; Toyama Y; Hirohashi S; Kawai A; Yamada T
Mol Cancer Ther; 2010 Mar; 9(3):535-44. PubMed ID: 20159990
[TBL] [Abstract][Full Text] [Related]
2. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.
Thongkum A; Wu C; Li YY; Wangpaichitr M; Navasumrit P; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Ruchirawat M; Savaraj N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587170
[TBL] [Abstract][Full Text] [Related]
3. Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase.
Feun LG; Marini A; Walker G; Elgart G; Moffat F; Rodgers SE; Wu CJ; You M; Wangpaichitr M; Kuo MT; Sisson W; Jungbluth AA; Bomalaski J; Savaraj N
Br J Cancer; 2012 Apr; 106(9):1481-5. PubMed ID: 22472884
[TBL] [Abstract][Full Text] [Related]
4. Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma.
Wu L; Li L; Meng S; Qi R; Mao Z; Lin M
J Gastroenterol Hepatol; 2013 Feb; 28(2):365-8. PubMed ID: 23339388
[TBL] [Abstract][Full Text] [Related]
5. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
[TBL] [Abstract][Full Text] [Related]
6. Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model.
Shiue SC; Huang MZ; Tsai TF; Chang AC; Choo KB; Huang CJ; Su TS
J Biomed Sci; 2015 Jan; 22(1):10. PubMed ID: 25616743
[TBL] [Abstract][Full Text] [Related]
7. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.
Dalla-Torre CA; Yoshimoto M; Lee CH; Joshua AM; de Toledo SR; Petrilli AS; Andrade JA; Chilton-MacNeill S; Zielenska M; Squire JA
BMC Cancer; 2006 Oct; 6():237. PubMed ID: 17022822
[TBL] [Abstract][Full Text] [Related]
8. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.
Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G
PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412
[TBL] [Abstract][Full Text] [Related]
9. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.
Dillon BJ; Prieto VG; Curley SA; Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
Cancer; 2004 Feb; 100(4):826-33. PubMed ID: 14770441
[TBL] [Abstract][Full Text] [Related]
10. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
11. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
15. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
[TBL] [Abstract][Full Text] [Related]
16. Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.
Kim Y; Kobayashi E; Kubota D; Suehara Y; Mukaihara K; Akaike K; Ito A; Kaneko K; Chuman H; Kawai A; Kitano S
Oncotarget; 2016 Oct; 7(43):70832-70844. PubMed ID: 27683125
[TBL] [Abstract][Full Text] [Related]
17. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
19. Arginine deprivation as a targeted therapy for cancer.
Feun L; You M; Wu CJ; Kuo MT; Wangpaichitr M; Spector S; Savaraj N
Curr Pharm Des; 2008; 14(11):1049-57. PubMed ID: 18473854
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
